Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Dtg Printing'

Dtg Printing published presentations and documents on DocSlides.

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

  • luanne-stotts
  • 31 Slides

Progressive rises in weight and clinical obesity ...

DTG + 3TC versus DTG + TDF-FTC as Initial ART

DTG + 3TC versus DTG + TDF-FTC as Initial ART

  • della
  • 17 Slides

GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

  • iris
  • 11 Slides

ADVANCE. . Design. Primary endpoint. Proportion ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

  • kylo
  • 31 Slides

Andrew Hill, Francois Venter, Eric . Delaporte. , ...

DTG-Based Regimens Are Active in INI-Naive Patients With a

DTG-Based Regimens Are Active in INI-Naive Patients With a

  • trish-goza
  • 14 Slides

Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

  • karlyn-bohler
  • 10 Slides

STRIIVING . Study. Design. Endpoints. Primary: pr...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

  • celsa-spraggs
  • 0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

  • lam
  • 10 Slides

Endpoints. Primary: proportion of patients with HI...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

  • jasmine
  • 15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

  • oryan
  • 37 Slides

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

  • winnie
  • 12 Slides

by Baseline NRTI Resistance . and Second-Line NRTI...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

  • jacey
  • 17 Slides

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 17 Slides

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 6 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

  • luanne-stotts
  • 0 Slides

and 22. nd. International AIDS Conference . Sele...

Updated WHO Treatment Guidelines &

Updated WHO Treatment Guidelines &

  • mitsue-stanley
  • 0 Slides

Data . from other . cohorts and . regions to guid...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

  • aaron
  • 0 Slides

2. Instituto Nacional de Ciencias Médicas y Nutr...

New regimen for $75 a year

New regimen for $75 a year

  • tawny-fly
  • 0 Slides

New pricing agreement will speed up access to gen...

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

  • liane-varnes
  • 0 Slides

July 24 2018 . Overview on Safety of HIV Treatmen...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

  • myesha-ticknor
  • 0 Slides

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Potential safety issue affecting women living with HIV using

Potential safety issue affecting women living with HIV using

  • luanne-stotts
  • 0 Slides

dolutegravir. at the time of conception. Meg Doh...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

  • faustina-dinatale
  • 0 Slides

and 22. nd. International AIDS Conference . Sele...

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

  • liane-varnes
  • 12 Slides

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...

Dolutegravir monotherapy

Dolutegravir monotherapy

  • alexa-scheidler
  • 15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

  • alida-meadow
  • 22 Slides

Heather Watts MD Director of HIV Prevention, Pro...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

  • trish-goza
  • 15 Slides

1 Queen Mary University, London, United Kingdom; ...

What’s New in WHO Treatment Guidelines

What’s New in WHO Treatment Guidelines

  • aaron
  • 28 Slides

July 23 2018 . What We Know About Safety Signals ...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

  • mediumgeneral
  • 12 Slides

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

The SA National PMTCT Guidelines (2019)

The SA National PMTCT Guidelines (2019)

  • cleminal
  • 49 Slides

Outline. The ideal PMTCT pathway . Detail of new i...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

  • mediumgeneral
  • 10 Slides

QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...

WHO ARV Forecasting Meeting

WHO ARV Forecasting Meeting

  • sistertive
  • 31 Slides

Geneva, March 19 - 20 , 2015 1 | Treatment and C...

Paediatric ARV Drug Optimization 3 Review Summary report &

Paediatric ARV Drug Optimization 3 Review Summary report &

  • neoiate
  • 15 Slides

*\n\b...

HIV History successes and lessons learned

HIV History successes and lessons learned

  • linda
  • 13 Slides

PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...

Clinical considerations for the

Clinical considerations for the

  • helene
  • 21 Slides

introduction . of . DTG. Nandita Sugandhi. ICAP at...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

  • brown
  • 34 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Meg Doherty MD MPH PhD 23 July 2018

Meg Doherty MD MPH PhD 23 July 2018

  • jordyn
  • 41 Slides

WHO HQ. The role of DTG based regimens in first- a...

Country Experience in Monitoring New

Country Experience in Monitoring New

  • fauna
  • 12 Slides

ARVs: Focus on Toxicity Monitoring . and Surveill...

Neuropsychiatric manifestations and

Neuropsychiatric manifestations and

  • Mindbender
  • 15 Slides

sleep disturbances in children and adolescents ran...

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

  • ethlyn
  • 9 Slides

Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...

Copyright © 2024 DocSlides. All Rights Reserved